BioStone AsurDx™ bELISA and iELISA for African Swine Fever have been evaluated by OIE ASF Reference Laboratory and published in Pathogens.

News

DALLAS-FORT WORTH, TX — November 12, 2024— BioStone Animal Health is pleased to announce that evaluation of our AsurDx™ bELISA and iELISA for African Swine Fever (ASF) antibody was published on November 8, 2024, in the peer-reviewed journal, Pathogens [1]. The evaluation was conducted at the National Center for Foreign Animal Disease (NCFAD, Winnipeg, Canada), which is one…

BioStone Animal Health was Awarded Research Grant for Development of African swine fever (ASF) DIVA Tests

News

DALLAS-FORT WORTH, TX — October 29, 2024— BioStone Animal Health is pleased to announce that the GenScript Life Science Research Grant Program has awarded BioStone Animal Health a grant to investigate and develop DIVA diagnostics for African swine fever (ASF). GenScript Life Science Research Grant Program (www.genscript.com ), a new initiative dedicated to supporting breakthroughs in life…

BioStone Animal Health Launches Rabies Antibody Test Kit

News

DALLAS-FORT WORTH, TX— February 16, 2024 — BioStone Animal Health is pleased to announce that the launch of the AsurDxTM Rabies Antibody Test Kit designed for the detection of antibodies specific to rabies virus in mammalian serum samples. The rabies virus is a member of the order Mononegavirales, viruses with a nonsegmented, negative-stranded RNA genomes. Within this…